MRSN - Mersana Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - MRSN (1442836)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
25 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-10-28
MRSNBala MohanSVP, Chief Development OfficerS - Sale+OE$1.90-1,88454,731-3%-$3,580
DM
2024-10-02
MRSNDeschuytner BrianSVP, COO, CFOS - Sale+OE$1.98-13,68794,824-13%-$27,150
DM
2024-10-02
MRSNCarvajal AlejandraSVP, GCS - Sale+OE$1.98-13,68763,716-18%-$27,150
DM
2024-10-02
MRSNBala MohanSVP, Chief Development OfficerS - Sale+OE$1.98-13,68750,365-21%-$27,150
DM
2024-10-02
MRSNMandelia AshishVP, Chief Accounting OfficerS - Sale+OE$1.98-8,21647,757-15%-$16,298
DM
2024-10-02
MRSNLowinger Timothy BSVP, Chief Sci., Tech. OfficerS - Sale+OE$1.98-13,687235,642-5%-$27,150
D
2024-09-12
MRSNHuber Martin H. Jr.Pres, CEOS - Sale+OE$1.76-50,423116,327-30%-$88,744
D
2024-01-16
MRSNProtopapas AnnaDirS - Sale+OE$2.71-29,399437,660-6%-$79,671
D
2024-01-16
MRSNMisra TusharSVP, Chief Manuf. OfficerS - Sale+OE$2.71-3,35717,966-16%-$9,097
D
2024-01-16
MRSNMandelia AshishVP, Chief Accounting OfficerS - Sale+OE$2.71-5,02523,328-18%-$13,618
D
2024-01-16
MRSNLowinger Timothy BSVP, Chief Sci., Tech. OfficerS - Sale+OE$2.71-10,409199,329-5%-$28,208
D
2024-01-16
MRSNCarvajal AlejandraSVP, GCS - Sale+OE$2.71-4,38127,403-14%-$11,873
D
2024-01-16
MRSNDeschuytner BrianSVP, COO, CFOS - Sale+OE$2.71-9,32754,511-15%-$25,276
D
2024-01-16
MRSNBala MohanSVP, Chief Development OfficerS - Sale+OE$2.71-3,43114,052-20%-$9,298
D
2023-10-26
MRSNBala MohanSVP, Chief Development OfficerS - Sale+OE$1.13-1,9128,733-18%-$2,161
D
2023-08-17
MRSNMisra TusharSVP, Chief Manuf. OfficerS - Sale+OE$1.18-1,90811,507-14%-$2,251
D
2023-04-27
MRSNCarvajal AlejandraSVP, GCS - Sale+OE$3.89-3,94420,326-16%-$15,342
D
2023-01-17
MRSNYang ArvinSVP, Chief Medical OfficerS - Sale+OE$5.74-2,20930,821-7%-$12,680
D
2023-01-17
MRSNProtopapas AnnaPres, CEOS - Sale+OE$5.74-17,346361,240-5%-$99,566
D
2023-01-17
MRSNMandelia AshishVP, ControllerS - Sale+OE$5.74-3,57513,619-21%-$20,521
D
2023-01-17
MRSNMisra TusharSVP, CMOS - Sale+OE$5.74-4585,930-7%-$2,629
D
2023-01-17
MRSNLowinger Timothy BSVP, Chief Sci., Tech. OfficerS - Sale+OE$5.74-6,233180,363-3%-$35,777
D
2023-01-17
MRSNDeschuytner BrianSVP, CFOS - Sale+OE$5.74-5,13132,781-14%-$29,452
D
2023-01-17
MRSNCarvajal AlejandraSVP, GCS - Sale+OE$5.74-78211,020-7%-$4,489
D
2022-12-01
MRSNYang ArvinChief Medical OfficerS - Sale+OE$6.59-5,52725,946-18%-$36,423

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top